• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Viking Thera (NQ: VKTX )

72.54 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Viking Thera

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
18 19 Next >
Forget Viking Therapeutics. Here's 1 Weight-Loss Stock to Keep Your Eyes on Instead.
April 09, 2024
Viking Therapeutics has garnered a lot of attention following a successful clinical trial for its obesity care drug. But another development-stage biotech may have a superior candidate. 
Via The Motley Fool
Can Altimmune get its GLP-1 Drug to Market Before Cash Rush Out?
April 09, 2024
Altimmune has a GLP-1 candidate in Phase 2 trials, but the company continues to burn cash and may need a big pharma partner to get its drug to market 
Via MarketBeat
Exposures Product Safety
Viking Therapeutics Is Great. Here's Why You Shouldn't Buy It.
April 08, 2024
Shares of the clinical-stage biotech have skyrocketed on recent good news. 
Via The Motley Fool
Is it Too Late to Buy Viking Therapeutics Stock?
April 06, 2024
Viking Therapeutics stock is on fire following a successful phase 2 trial for its obesity care candidate. 
Via The Motley Fool
MarketBeat Week in Review – 4/1 - 4/5
April 06, 2024
Equities lost ground this week as investors consider the effect of fewer rate cuts, rising oil prices, and robust job gains ahead of a new earnings season 
Via MarketBeat
Topics Economy
Exposures Interest Rates
Viking Therapeutics Just Announced More Positive Results: Time to Buy?
April 04, 2024
The drugmaker isn't losing momentum. 
Via The Motley Fool
$1000 Invested In This Stock 5 Years Ago Would Be Worth $6,900 Today
April 02, 2024
Via Benzinga
Better Booming Biotech Stock: Madrigal Pharmaceuticals vs. Viking Therapeutics
April 05, 2024
These businesses should see good times ahead. 
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
April 04, 2024
Via Benzinga
1 Brand-New (Good) Reason to Buy Viking Therapeutics Stock Now
April 04, 2024
Its long-term growth potential looks like it's improving, again. 
Via The Motley Fool
2 Potentially Explosive Stocks to Buy in April
April 04, 2024
These two healthcare stocks should have plenty of room to run. 
Via The Motley Fool
Could This 1 Detail Help Viking Therapeutics Top Eli Lilly and Novo Nordisk in the Weight Loss Drug Market?
April 04, 2024
Viking shares have soared recently on optimism about its program. 
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
April 03, 2024
Via Benzinga
Looking Into Viking Therapeutics's Recent Short Interest
April 01, 2024
Via Benzinga
Viking Therapeutics Surges Sentiment for Triple Threat GLP-1Pill
April 03, 2024
Viking Therapeutics is preparing to be the next entry into the GLP-1 Market, and VKTX stock is soaring as analysts start to bid the stock higher 
Via MarketBeat
Exposures Product Safety
5 Healthcare Stocks to Buy for 2024
April 02, 2024
Healthcare stocks have been some of the top performers in 2024, and thanks to the potential of AI, these names will just keep heating up. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Merger Mania: 3 Potential Takeover Targets to Watch for Lucrative Buyouts
April 02, 2024
With interest rates poised to fall, acquisitions will become more numerous. Here are three potential takeover targets. 
Via InvestorPlace
Tuesday Talk: April Is The Cruelest Month?
April 02, 2024
At least that is what the poet T.S. Eliot wrote in the opening line of his well-known poem, 
Via Talk Markets
Could Viking Therapeutics Stock Be a Millionaire Maker?
April 02, 2024
There is a plausible path for this biotech stock to make some investors millionaires. 
Via The Motley Fool
Russell 2000 Index Best And Worst Performing Stocks Of 2024
April 02, 2024
The Russell 2000 index continued to underperform the Dow Jones and Nasdaq 100 indices in the first quarter of 2024. 
Via Talk Markets
Topics Stocks
Exposures US Equities
The 3 Best Biotech Stocks to Buy in April 2024
April 01, 2024
Biotech is one of the hottest sectors on the market, creating big opportunities for some of the best biotech stocks to buy in April. 
Via InvestorPlace
Viking Therapeutics Stock Has 72% Upside, According to 1 Wall Street Analyst
April 01, 2024
The company's experimental new weight-management drug looks great so far. 
Via The Motley Fool
2 Top Biotech Buyout Candidates
March 31, 2024
Investors who are adventurous, have a high-risk tolerance, and are home run hitters may opt for biotech stocks. Investors in this group may want to hone in on stocks that have the potential to be... 
Via Talk Markets
Prediction: Pfizer Won't Acquire Viking Therapeutics. Here's Why.
March 31, 2024
Viking Therapeutics may be the next company to enter the red-hot weight loss space. 
Via The Motley Fool
5 Top Stocks to Buy in April
March 31, 2024
Whether you're looking for high-powered growth or stable passive income, this basket of top stocks has it all. 
Via The Motley Fool
The 3 Best Russell 2000 Stocks to Buy in Q2 2024
March 30, 2024
Find out about the three best small-cap stocks in the best Russell 2000 to buy this upcoming quarter for significant returns. 
Via InvestorPlace
Is It Too Late to Buy Viking Therapeutics Stock?
March 29, 2024
Shares of Viking Therapeutics have skyrocketed more than 350% this year. 
Via The Motley Fool
Better Buy: Viking Therapeutics vs. Madrigal Pharmaceuticals
March 29, 2024
Both stocks are pretty risky, but one of them more so than the other. 
Via The Motley Fool
Why Viking Therapeutics Stock Was Rocketing Higher This Week
March 29, 2024
Good news from the lab and subsequent price target lifts by analysts put some zip into the company's shares. 
Via The Motley Fool
Stock Market Rally Shows Breadth As Leaders Take A Breath: Weekly Review
March 28, 2024
The stock market rally showed breadth, with small caps leading the way to a 24-month high. Growth leaders like Nvidia took a break. 
Via Investor's Business Daily
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
18 19 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap